Literature DB >> 24848090

Allergic reactions to antibiotics in children.

Tahia D Fernandez1, Cristobalina Mayorga, Adriana Ariza, Jose L Corzo, Maria J Torres.   

Abstract

PURPOSE OF REVIEW: To analyze recent findings on antibiotic hypersensitivity reactions in children focusing on betalactams, with regard to clinical entities, antibiotics involved and diagnostic methods. RECENT
FINDINGS: Betalactams are the most frequent cause of antibiotic hypersensitivity, more specifically amoxicillin alone or with clavulanic acid, with selective reactions to clavulanic acid also recently reported. Cephalosporins are the second most frequent group involved, especially in countries with high consumption. Other antibiotics such as sulphamides and macrolides although involved are less common. There are two types of reactions, immediate and nonimmediate, the latter being more frequent. Diagnosis is complex and is confirmed in less than 10% of children evaluated, twice as often in immediate than in nonimmediate reactions. Clinical history is often unreliable. Regarding other methods, skin testing and in-vitro methods can be useful for immediate reactions; however, most nonimmediate reactions need drug provocation tests for diagnosis. There are different degrees of cross-reactivity between penicillin and cephalosporins, with the side-chain being critical for determination.
SUMMARY: Betalactams are the antibiotics most frequently involved in hypersensitivity reactions with amoxicillin being the main culprit drug. Immediate reactions, although less frequent, are more often confirmed, with skin testing still relevant for their diagnosis. Nonimmediate reactions are usually diagnosed by drug provocation test.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24848090     DOI: 10.1097/ACI.0000000000000069

Source DB:  PubMed          Journal:  Curr Opin Allergy Clin Immunol        ISSN: 1473-6322


  8 in total

Review 1.  Antibiotic Allergy in Pediatrics.

Authors:  Allison Eaddy Norton; Katherine Konvinse; Elizabeth J Phillips; Ana Dioun Broyles
Journal:  Pediatrics       Date:  2018-05       Impact factor: 7.124

Review 2.  Non-immediate Cutaneous Reactions to Beta-Lactams: Approach to Diagnosis.

Authors:  Antonino Romano; Rocco Luigi Valluzzi; Cristiano Caruso; Michela Maggioletti; Francesco Gaeta
Journal:  Curr Allergy Asthma Rep       Date:  2017-04       Impact factor: 4.919

3.  Immediate and non-immediate allergic reactions to amoxicillin present a diagnostic dilemma: a case series.

Authors:  Caroline Weisser; Moshe Ben-Shoshan
Journal:  J Med Case Rep       Date:  2016-01-18

Review 4.  Pro and Contra: Provocation Tests in Drug Hypersensitivity.

Authors:  Ozge Soyer; Umit Murat Sahiner; Bulent Enis Sekerel
Journal:  Int J Mol Sci       Date:  2017-07-04       Impact factor: 5.923

5.  Cephalosporins-induced intestinal dysbiosis exacerbated pulmonary endothelial barrier disruption in streptococcus pneumoniae-infected mice.

Authors:  Jia-Feng Wang; Chang-Yi Shi; Hua-Zhong Ying
Journal:  Front Cell Infect Microbiol       Date:  2022-08-24       Impact factor: 6.073

6.  Stamping a Case of Cutaneous Adverse Drug Reaction: Proving Beyond Causality Assessment.

Authors:  Sudip Das; Projna Biswas; Dayamay Pal; Abhishek De
Journal:  Indian J Dermatol       Date:  2018 Mar-Apr       Impact factor: 1.494

7.  Non-immediate hypersensitivity reactions to beta-lactam antibiotics in children - our 10-year experience in allergy work-up.

Authors:  Marina Atanaskovic-Markovic; Francesco Gaeta; Biljana Medjo; Marija Gavrovic-Jankulovic; Tanja Cirkovic Velickovic; Vladimir Tmusic; Antonino Romano
Journal:  Pediatr Allergy Immunol       Date:  2016-05-06       Impact factor: 6.377

8.  Safety of direct oral provocation testing using the Amoxicillin-2-step-challenge in children with history of non-immediate reactions to amoxicillin.

Authors:  Vanlaya Koosakulchai; Pasuree Sangsupawanich; Duangdee Wantanaset; Wipa Jessadapakorn; Pondtip Jongvilaikasem; Araya Yuenyongviwat
Journal:  World Allergy Organ J       Date:  2021-07-09       Impact factor: 4.084

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.